MedTrace Logo

The Effect of Strength Training and Protein Supplementation in Old Pre-frail Individuals

NCT03723902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-03-14

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of a lower-body strength training regime combined with protein supplementation in pre-frail elderly individuals. Participants are randomized to a group performing three weekly sessions of heavy-load strength training for 10 weeks and receiving daily protein supplementation, or a non-training, non-supplemented control group. The endpoints are changes in body composition, the relative changes in different compartments of the quadriceps femoris muscles, and the relationships between changes in muscle mass, muscle thickness, strength, and functional capacity. The investigators hypothesize that 10 weeks of heavy load strength training and protein supplementation will elicit improvements in muscle mass, strength, and functional performance. Moreover, it is hypothesized that improvements in strength will correlate with the improvements in functional performance.

Conditions

  • Aging

Interventions

OTHER

Heavy-load strength training

Three weekly sessions of heavy-load strength training for 10 weeks

DIETARY_SUPPLEMENT

Protein supplementation

Daily supplementation of 2 x 17 grams of milk protein

Sponsors & Collaborators

  • Norwegian School of Sport Sciences

    lead OTHER

Principal Investigators

  • Truls Raastad, Prof. · Norwegian School of Sport Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2015-12-21
Completion
2015-12-21

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03723902 on ClinicalTrials.gov